These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


621 related items for PubMed ID: 8864988

  • 21. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E, Pecquet S, Rojas J, Couvreur P, Fattal E.
    J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
    [Abstract] [Full Text] [Related]

  • 22. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
    Rawat A, Burgess DJ.
    Int J Pharm; 2010 Jul 15; 394(1-2):99-105. PubMed ID: 20472046
    [Abstract] [Full Text] [Related]

  • 23. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S, Janoria KG, Mitra AK.
    J Control Release; 2005 Nov 28; 108(2-3):282-93. PubMed ID: 16229919
    [Abstract] [Full Text] [Related]

  • 24. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering.
    Andreas K, Zehbe R, Kazubek M, Grzeschik K, Sternberg N, Bäumler H, Schubert H, Sittinger M, Ringe J.
    Acta Biomater; 2011 Apr 28; 7(4):1485-95. PubMed ID: 21168535
    [Abstract] [Full Text] [Related]

  • 25. Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique.
    Mandal TK, Lopez-Anaya A, Onyebueke E, Shekleton M.
    J Microencapsul; 1996 Apr 28; 13(3):257-67. PubMed ID: 8860682
    [Abstract] [Full Text] [Related]

  • 26. Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies.
    Jain D, Majumdar DK, Panda AK.
    J Biomater Appl; 2006 Oct 28; 21(2):195-211. PubMed ID: 16443624
    [Abstract] [Full Text] [Related]

  • 27. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q, Crossley A, Czernuszka J.
    J Pharm Sci; 2009 Jul 28; 98(7):2377-89. PubMed ID: 19009589
    [Abstract] [Full Text] [Related]

  • 28. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M, Barar J, Valizadeh H, Shadrou S, Nokhodchi A.
    Pharm Dev Technol; 2011 Jul 28; 16(6):637-44. PubMed ID: 20722498
    [Abstract] [Full Text] [Related]

  • 29. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T, Goto S, Foster TP.
    J Pharm Pharmacol; 1995 Jul 28; 47(7):556-60. PubMed ID: 8568620
    [Abstract] [Full Text] [Related]

  • 30. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR, Elkharraz K, Irfan M, Bodmeier R.
    Pharm Dev Technol; 2012 Jul 28; 17(1):66-72. PubMed ID: 20854130
    [Abstract] [Full Text] [Related]

  • 31. Preparation of protein-loaded sustained-release microspheres via 'solid-in-oil-in-hydrophilic oil-in-ethanol (S/O/hO/E)' emulsification.
    Yuan W, Zhang Y, Wu F, Li H, Cai Y, Zhang Y, Han M, Jin T.
    Colloids Surf B Biointerfaces; 2010 Sep 01; 79(2):326-33. PubMed ID: 20483570
    [Abstract] [Full Text] [Related]

  • 32. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
    Ansary RH, Rahman MM, Awang MB, Katas H, Hadi H, Doolaanea AA.
    Drug Deliv Transl Res; 2016 Jun 01; 6(3):308-18. PubMed ID: 26817478
    [Abstract] [Full Text] [Related]

  • 33. Properties of multiphase microspheres of poly(D,L-lactic-co-glycolic acid) prepared by a potentiometric dispersion technique.
    O'Donnell PB, Iwata M, McGinity JW.
    J Microencapsul; 1995 Jun 01; 12(2):155-63. PubMed ID: 7629658
    [Abstract] [Full Text] [Related]

  • 34. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M, Sakai Y, Yoshida M, Haraguchi T, Morisaki T, Uchida T.
    J Pharm Pharmacol; 2011 Mar 01; 63(3):362-8. PubMed ID: 21749383
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
    Smeets R, Gerhards F, Stein JM, Paz RM, Vogt S, Pautke C, Weitz J, Kolk A.
    J Biomed Mater Res A; 2011 Jan 01; 96(1):177-85. PubMed ID: 21105166
    [Abstract] [Full Text] [Related]

  • 38. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S, Faraj J, DeLuca P.
    Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt A):631-9. PubMed ID: 23892159
    [Abstract] [Full Text] [Related]

  • 39. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin.
    Uchida T, Yoshida K, Ninomiya A, Goto S.
    Chem Pharm Bull (Tokyo); 1995 Sep 01; 43(9):1569-73. PubMed ID: 7586084
    [Abstract] [Full Text] [Related]

  • 40. Effect of different dispersing agents on the characteristics of Eudragit microspheres prepared by a solvent evaporation method.
    Horoz BB, Kiliçarslan M, Yüksel N, Baykara T.
    J Microencapsul; 2004 Mar 01; 21(2):191-202. PubMed ID: 15198430
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.